Literature DB >> 28181077

Response to commentary on "Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision".

B Ma1, P Gao1, Z Wang2.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28181077     DOI: 10.1007/s10151-017-1587-y

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


× No keyword cloud information.
  5 in total

Review 1.  Laparoscopic Versus Open Surgery for Mid-Low Rectal Cancer: a Systematic Review and Meta-Analysis on Short- and Long-Term Outcomes.

Authors:  Jin-bo Jiang; Kun Jiang; Yong Dai; Ru-xia Wang; Wei-zhi Wu; Jing-jing Wang; Fu-Bo Xie; Xue-Mei Li
Journal:  J Gastrointest Surg       Date:  2015-06-04       Impact factor: 3.452

2.  Transanal Mesorectal Excision: The New Challenge in Rectal Cancer.

Authors:  Eric Rullier
Journal:  Dis Colon Rectum       Date:  2015-07       Impact factor: 4.585

Review 3.  Comparison of short-term clinical outcomes between transanal and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: A meta-analysis.

Authors:  W Xu; Z Xu; H Cheng; J Ying; F Cheng; W Xu; J Cao; J Luo
Journal:  Eur J Surg Oncol       Date:  2016-09-19       Impact factor: 4.424

4.  Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer.

Authors:  B L Green; H C Marshall; F Collinson; P Quirke; P Guillou; D G Jayne; J M Brown
Journal:  Br J Surg       Date:  2012-11-06       Impact factor: 6.939

Review 5.  Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision.

Authors:  Bin Ma; Peng Gao; Yongxi Song; Cong Zhang; Changwang Zhang; Longyi Wang; Hongpeng Liu; Zhenning Wang
Journal:  BMC Cancer       Date:  2016-07-04       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.